Citadel Advisors’s Houghton Mifflin Harcourt Company HMHC Stock Holding History

Citadel Advisors’s Portfolio HMHC Stock Details HMHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-43,700	Closed	-$918K	–	14894
2022 Q1	$918K	Buy	43,700 +6,600	+18%	+$124K	﹤0.01%	7916
2021 Q4	$597K	Buy	37,100 +5,200	+16%	+$79.1K	﹤0.01%	9237
2021 Q3	$428K	Sell	31,900 -36,300	-53%	-$457K	﹤0.01%	10254
2021 Q2	$753K	Buy	68,200 +37,400	+121%	+$352K	﹤0.01%	9093
2021 Q1	$235K	Sell	30,800 -28,500	-48%	-$163K	﹤0.01%	11391
2020 Q4	$197K	Buy	59,300 +22,800	+62%	+$67.9K	﹤0.01%	9743
2020 Q3	$63K	Buy	+36,500	New	+$81.5K	﹤0.01%	9516
2016 Q3	–	Sell	-10,200	Closed	-$159K	–	7967
2016 Q2	$159K	Buy	+10,200	New	+$185K	﹤0.01%	5988

Other funds holding HMHC

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Citadel Advisors's HMHC Position: Q2 2022 in Review

Citadel Advisors sold out of Houghton Mifflin Harcourt Company (HMHC) in Q2 2022, closing a stake of 128,483 shares — an estimated $2.7M sold.

Citadel Advisors first reported a position in HMHC in Q4 2013 and held it in 30 quarters. The position peaked at $8.3M in Q3 2015. 1 fund tracked by Wall St. Rank holds HMHC as of Q2 2022.

Citadel Advisors reported no remaining Houghton Mifflin Harcourt Company position as of Q2 2022 after selling out during the quarter.
Citadel Advisors sold 128,483 Houghton Mifflin Harcourt Company shares in Q2 2022, an estimated $2.7M.
Citadel Advisors first reported a position in Houghton Mifflin Harcourt Company in Q4 2013 and held it in 30 quarters.
Citadel Advisors's Houghton Mifflin Harcourt Company position peaked at $8.3M in Q3 2015.
1 fund tracked by Wall St. Rank held Houghton Mifflin Harcourt Company as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.